Bladder Cancer

BLADDER CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

The Vital Role Genetic Testing Plays in Bladder Cancer Treatments

Recent research suggests cancer patients who have undergone genetic testing for inherited or acquired mutations were more likely to have prolonged overall survival than patients who did not,
FDA Label Restriction Triggers Increased Uptake of PD-L1 Assays in Urothelial Carcinoma

FDA label changes for certain immunotherapies may have prompted a marked increase in the use of PD-L1 assays.
Thawing Frozen Cancer Drug Labels

As medical care rapidly evolves, there’s really no debate over the potential for drug labels to become outdated, particularly in the high stakes world of cancer treatment. The question is how best to ameliorate the problem, while still protecting the process from financial and other conflicts. Off-label prescribing of cancer drugs is common, occurring 30%…
Adding Gemcitabine at the Time of Resection Reduces Recurrence, Cost in Early-Stage Bladder Cancer

Though early-stage bladder cancer is infrequently fatal, the decrease in recurrence rates has a meaningful impact on the quality of life for patients as well as treatment costs.
Muscle-Invasive Bladder Cancer: The Evolving Treatment Landscape

Patients diagnosed with MIBC are at a significant risk for death — which has not greatly improved in the last few decades.

VIDEO SERIES

Immunotherapy for Advanced Bladder Cancer: The Next Frontier

Bladder-sparing Strategies

Intravesical Therapy: When Bacillus Calmette-Guerin Fails

AUA Guidelines: Non-muscle Invasive Bladder Cancer

Bladder Cancer Biomarkers: New and Old

Current Research and New Treatments

PD-L1 Inhibitors Changing the Standard of Care

The Emergence of Personalized Medicine

BLADDER CANCER NEWS

Bone with cancer

Radiation for Abdominal, Pelvic Cancers Ups Secondary Sarcoma Risk

October 5, 2020

Multiple patients having chemotherapy in a room

Neoadjuvant and Adjuvant Chemo More Effective Than RNU Alone in UTUC

October 2, 2020

Patients and doctor in infusion room

Neoadjuvant Chemo May Improve Overall Survival in UTUC

September 24, 2020

doctors performing surgery

EAU Issues Updated UTUC Guidelines

September 17, 2020

Flexible Ureteroscope

Data Support Ureteroscopy for Upper Tract Urothelial Carcinoma

August 26, 2020

Next post in Bladder Cancer

Patients and doctor in infusion room

Neoadjuvant Chemo May Improve Overall Survival in UTUC